The phase 3 IDeate-Esophageal01 study of ifinatamab deruxtecan has dosed its first patient with esophageal squamous cell carcinoma.

Dysphagia is a common early symptom of esophageal cancer, often confused with digestive issues, delaying diagnosis. Treatment varies by cancer stage; early-stage often involves surgery and ...

Drs Samuel Klempner and Geoffrey Ku deep dive into all things esophageal squamous cell cancer, including detection, staging, and treatment.

Esophageal cancer (esophageal carcinoma) is a rare and sometimes aggressive cancer that occurs in the esophagus, connecting the mouth to the stomach.

Conversion surgery for tislelizumab combined chemotherapy for T4a/N3 esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study.

There are two main subtypes of esophageal cancer — esophageal adenocarcinoma and esophageal squamous cell carcinoma. The majority of esophageal cancer diagnoses in the U.S. are adenocarcinoma.

Stage 4 esophageal cancer is an advanced for of cancer. Learn about symptom, treatments, diagnosis, survival rates, and more.

Key Takeaway Esophagectomy for esophageal squamous cell carcinoma (ESCC) should be performed 6–8 weeks after the end of neoadjuvant chemotherapy.

Abstract e16045 Background: Currently, the real-world evidence is not available to support the practice of induction immunochemotherapy (iIC) plus conversion surgery for initially-unresectable ...

The addition of docetaxel to cisplatin and 5-FU chemotherapy significantly extended OS as neoadjuvant therapy for local advanced esophageal squamous cell cancer, according to results of a ...

Esophageal cancer, the seventh most common cancer globally, accounts for more than half a million deaths each year. 1 The incidence of esophageal squamous-cell carcinoma, the most common ...